메뉴 건너뛰기




Volumn 14, Issue 1, 2013, Pages

Randomized trial of Legflow® paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): Study protocol for a randomized controlled trial

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL; PACLITAXEL;

EID: 84875335925     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-87     Document Type: Article
Times cited : (16)

References (16)
  • 1
    • 33846497950 scopus 로고    scopus 로고
    • Inter-society consensus for the management of peripheral arterial disease (TASC II)
    • TASC II Working Group
    • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007, 45(Suppl S):S5-S67. TASC II Working Group.
    • (2007) J Vasc Surg , vol.45 , Issue.SUPPL. S
    • Norgren, L.1    Hiatt, W.R.2    Dormandy, J.A.3    Nehler, M.R.4    Harris, K.A.5    Fowkes, F.G.6
  • 4
    • 34249684339 scopus 로고    scopus 로고
    • Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting
    • 10.1161/CIRCULATIONAHA.107.688341, 17502568
    • Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007, 115:2745-2749. 10.1161/CIRCULATIONAHA.107.688341, 17502568.
    • (2007) Circulation , vol.115 , pp. 2745-2749
    • Schillinger, M.1    Sabeti, S.2    Dick, P.3    Amighi, J.4    Mlekusch, W.5    Schlager, O.6    Loewe, C.7    Cejna, M.8    Lammer, J.9    Minar, E.10
  • 6
    • 54049125687 scopus 로고    scopus 로고
    • Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial
    • 10.1161/CIRCULATIONAHA.107.735985, 18779447
    • Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008, 118:1358-1365. 10.1161/CIRCULATIONAHA.107.735985, 18779447.
    • (2008) Circulation , vol.118 , pp. 1358-1365
    • Werk, M.1    Langner, S.2    Reinkensmeier, B.3    Boettcher, H.F.4    Tepe, G.5    Dietz, U.6    Hosten, N.7    Hamm, B.8    Speck, U.9    Ricke, J.10
  • 10
    • 59649124035 scopus 로고    scopus 로고
    • Clinical validity of a disease-specific health status questionnaire: the peripheral artery questionnaire
    • 10.1016/j.jvs.2008.08.089, 19028064
    • Hoeks SE, Smolderen KG, Scholte Op Reimer WJ, Verhagen HJ, Spertus JA, Poldermans D. Clinical validity of a disease-specific health status questionnaire: the peripheral artery questionnaire. J Vasc Surg 2009, 49:371-377. 10.1016/j.jvs.2008.08.089, 19028064.
    • (2009) J Vasc Surg , vol.49 , pp. 371-377
    • Hoeks, S.E.1    Smolderen, K.G.2    Scholte Op Reimer, W.J.3    Verhagen, H.J.4    Spertus, J.A.5    Poldermans, D.6
  • 11
    • 84055212209 scopus 로고    scopus 로고
    • Review of clinical data with Paccocath- coated balloon catheters [Review]
    • Schnorr B, Speck U, Scheller B. Review of clinical data with Paccocath- coated balloon catheters [Review]. Minerva Cardioangiol 2011, 59:431-45.
    • (2011) Minerva Cardioangiol , vol.59 , pp. 431-445
    • Schnorr, B.1    Speck, U.2    Scheller, B.3
  • 12
    • 77956828009 scopus 로고    scopus 로고
    • Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries
    • 10.1002/ccd.22468, 20839356
    • Pósa A, Nyolczas N, Hemetsberger R, Pavo N, Petnehazy O, Petrasi Z, Sangiorgi G, Gyöngyösi M. Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries. Catheter Cardiovasc Interv 2010, 76:395-403. 10.1002/ccd.22468, 20839356.
    • (2010) Catheter Cardiovasc Interv , vol.76 , pp. 395-403
    • Pósa, A.1    Nyolczas, N.2    Hemetsberger, R.3    Pavo, N.4    Petnehazy, O.5    Petrasi, Z.6    Sangiorgi, G.7    Gyöngyösi, M.8
  • 13
    • 84870894399 scopus 로고    scopus 로고
    • Aneurysm formation after drug-eluting balloon treatment of drug-eluting in-stent restenosis: First case report
    • 10.1002/ccd.23460, 22419657
    • Vassilev D, Hazan M, Dean L. Aneurysm formation after drug-eluting balloon treatment of drug-eluting in-stent restenosis: First case report. Catheter Cardiovasc Interv 2012, 80:1223-1226. 10.1002/ccd.23460, 22419657.
    • (2012) Catheter Cardiovasc Interv , vol.80 , pp. 1223-1226
    • Vassilev, D.1    Hazan, M.2    Dean, L.3
  • 14
    • 84863259451 scopus 로고    scopus 로고
    • Coronary pseudoaneurysm in a non-polymer drug-eluting stent: a rare entity
    • 10.1177/0218492311419766, 22160410
    • Kapoor A, Batra A, Kumar S, Pandey S, Agarwal SK, Sinha N. Coronary pseudoaneurysm in a non-polymer drug-eluting stent: a rare entity. Asian Cardiovasc Thorac Ann 2011, 19:407-410. 10.1177/0218492311419766, 22160410.
    • (2011) Asian Cardiovasc Thorac Ann , vol.19 , pp. 407-410
    • Kapoor, A.1    Batra, A.2    Kumar, S.3    Pandey, S.4    Agarwal, S.K.5    Sinha, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.